in ,

Experts Say Biden’s Booster Vaccine Push Is Premature, Not Enough Data, Testing And Regulatory Oversight To Approve

Boosters could be dangerous without proper testing

Credit: Pete Marovich/Abaca/Bloomberg


The White House’s plan to begin offering booster shots next month to almost all vaccinated U.S. adults is raising concerns among health experts that the administration is rushing ahead without enough data and regulatory oversight.

On Wednesday as expected, officials from the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention, along with the U.S. Surgeon General and White House Covid-19 adviser Anthony Fauci, announced the booster plan. But it came without the FDA and CDC publicly saying they had fully vetted giving a third shot to the 100 million fully-vaccinated Americans by year’s end.

Messenger RNA vaccines made by Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE will be used in the booster push, according to the announcement. Johnson & Johnson’s is still under review because it came into use later.

These vaccines were cleared under an emergency use authorization (EUA) that would have to be amended to allow the booster program to go forward.

Read More

Leave a Reply


Breaking: FBI Finds Little Evidence That U.S. Capitol Attack Was An Organized Plan To Overturn Presidential Election

Disastrous And Dangerous: Taliban Screening Names At Kabul Airport In Hunt For U.S. Allies, Many Americans Injured And Prevented From Boarding Planes